Product Portfolio

As a science-based healthcare company, we strive to develop products that can change the practice of medicine. Novartis is focused on three divisions with global scale and innovation power - pharmaceuticals, eye care and generic medicines.

A New Era of Medicine

Cell and gene therapies could help reduce or eliminate the need for treatments that need to be taken continuously, often for life. Novartis is reimagining medicine with one-time, potentially curative cell and gene therapies that only need to be administered once for patients with serious, rare and life-threatening diseases. These new therapies present the opportunity to reexamine how our healthcare system manages diagnosis, treatment, care and associated costs for these patients. Find out more here.

^{IE02/COR19-CNF050   December 2019}